Prevalence of obesity in patients receiving depot antipsychotics.
about
Pharmacological interventions for reducing weight gain in schizophreniaBehavioural interventions for reducing weight gain in schizophreniaAntipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problemsInterventions to reduce weight gain in schizophreniaAntipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problemsUsing internet enabled mobile devices and social networking technologies to promote exercise as an intervention for young first episode psychosis patients.Community care of patients with schizophrenia: the role of the primary health care teamImproving the physical health of patients with schizophrenia: therapeutic nihilism or realism?'Why getting fat, Doc?' Weight gain and psychotropic medications.Weight-gain in psychiatric treatment: risks, implications, and strategies for prevention and management.Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorderA bayesian translational framework for knowledge propagation, discovery, and integration under specific contexts.Antipsychotic drugs and obesity: is prolactin involved?Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats.Obesity in individuals with schizophrenia: a case controlled study in Scotland.Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment.Persistent hyperphagia in acquired brain injury; an observational case study of patients receiving inpatient rehabilitation.Anthropometry and adiposity in a group of people with chronic mental illness.
P2860
Q24194410-E9DD4823-F966-478A-95C3-8181F33ABB95Q24197824-CDE34120-12BD-4348-8FB1-AB97EC59EF51Q24235450-F8C762D8-E921-47B6-9CA8-049A9C981585Q24243093-F51B3880-129B-4543-AAE4-BD829ABFE24FQ24244736-A398842C-FC91-4CF0-87BB-3A655BC15B8DQ30501289-DBEE62F6-BDF0-446F-A3AA-1BDD26C8DC1AQ34054749-4A16B669-28A9-4B1F-9118-79BE2F5E45C4Q34223748-45BBCF63-0A3A-42B2-8D82-063D3573419BQ34299393-770D3B2E-8A88-4994-88D4-C336C2E7B946Q34543946-40A80415-A7B2-4CAE-A715-A7FEFDBE4F60Q36074188-FCED4456-FBA4-43A3-84AC-D966793CE292Q36082961-558AF547-86D8-490F-A950-2847F3D2C2B2Q40669926-2D304138-7256-43B7-9B01-A44498344CDBQ44169297-1D5AE1BB-7565-44E6-A3E4-5A57DC4C983FQ47136605-4C36CFD9-A602-4F9B-A1AF-E84C3BF97650Q47247035-D3804AE4-EFEC-428F-8536-98A7AAB799A5Q48166939-591C40C5-74E6-4AF5-A3C0-3672916DCD48Q51994977-914623B9-FF0B-4CD9-91F8-02DC2503A3A2
P2860
Prevalence of obesity in patients receiving depot antipsychotics.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Prevalence of obesity in patients receiving depot antipsychotics.
@en
Prevalence of obesity in patients receiving depot antipsychotics.
@nl
type
label
Prevalence of obesity in patients receiving depot antipsychotics.
@en
Prevalence of obesity in patients receiving depot antipsychotics.
@nl
prefLabel
Prevalence of obesity in patients receiving depot antipsychotics.
@en
Prevalence of obesity in patients receiving depot antipsychotics.
@nl
P2093
P356
P1476
Prevalence of obesity in patients receiving depot antipsychotics.
@en
P2093
P304
P356
10.1192/BJP.153.2.214
P407
P577
1988-08-01T00:00:00Z